![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
Abstract
Primary hypercalciuria (PH) is very often accompanied by some degree of bone demineralization. The most frequent clinical condition in which this association has been observed is calcium nephrolithiasis. In patients affected by this disorder, bone density is very frequently low, and increased susceptibility to fragility fractures is reported. The very poor definition of this bone disease from a histomorphometric point of view is a crucial aspect. At present, the most common finding seems to be a low bone turnover condition. Many factors are involved in the complex relationships between bone loss and PH. Since bone loss was mainly reported in patients with fasting hypercalciuria, a primary alteration in bone metabolism was proposed as a cause of both hypercalciuria and bone demineralization. This hypothesis was strengthened by the observation that some bone resorbing-cytokines, such as interleukin-1 (IL-1), interleukin-6 (IL-6), and tumor nechrosis factor-α (TNF-α), are high in hypercalciuric patients. An excessive response to the acid load induced by dietary protein intake seems to be an additional factor explaining a primitive alteration of bone.
The intestine plays a major role in the clinical course of bone disease in PH. Patients with absorptive hypercalciuria less frequently show bone disease, and a reduction in dietary calcium greatly increases the probability of bone loss in PH subjects. It has recently been reported that greater bone loss is associated with a larger increase in intestinal calcium absorption in PH patients. Considering the absence of parathyroid hormone (PTH) alterations, it was proposed that this is not a compensatory phenomenon, but probably the marker of disturbed cell calcium transport, involving both intestinal and bone tissues. While renal hypercalciuria is rather uncommon, the kidney still seems to play a role in the pathogenesis of bone loss in PH patients, possibly via the effect of mild-to-moderate urinary phosphate loss with secondary hypophosphatemia. In conclusion, bone loss is very common in PH patients. Even if most of the factors involved in this process have been identified, many aspects of this intriguing clinical condition remain to be elucidated.
| Abbreviations | ||
| DEXA | = | Dual Energy X-ray Absorptiometry |
| DPA | = | Dual Photon Absorptiometry |
| GM-CSF | = | Granulocyte-Macrophage Colony Stimulating Factor |
| HHRH | = | Hereditary Hypophosphatemic Rickets with Hypercalciuria |
| IL-1 | = | Interleukin-1 |
| IL-6 | = | Interleukin-6 |
| LPS | = | Lipopolysaccharide |
| NPT2 | = | Na-Pi Transporter 2 |
| PH | = | Primary Hypercalciuria |
| PTH | = | Parathyroid Hormone |
| QCT | = | Quantitative Computer Tomography |
| QUS | = | Quantitative Ultrasounds |
| SPA | = | Single Photon Absorptiometry; TmPi |
| TNF-α | = | Tumor Necrosis Factor-α |
| WHO | = | World Health Organization. |
| Abbreviations | ||
| DEXA | = | Dual Energy X-ray Absorptiometry |
| DPA | = | Dual Photon Absorptiometry |
| GM-CSF | = | Granulocyte-Macrophage Colony Stimulating Factor |
| HHRH | = | Hereditary Hypophosphatemic Rickets with Hypercalciuria |
| IL-1 | = | Interleukin-1 |
| IL-6 | = | Interleukin-6 |
| LPS | = | Lipopolysaccharide |
| NPT2 | = | Na-Pi Transporter 2 |
| PH | = | Primary Hypercalciuria |
| PTH | = | Parathyroid Hormone |
| QCT | = | Quantitative Computer Tomography |
| QUS | = | Quantitative Ultrasounds |
| SPA | = | Single Photon Absorptiometry; TmPi |
| TNF-α | = | Tumor Necrosis Factor-α |
| WHO | = | World Health Organization. |